Global Assets Advisory LLC cut its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 10.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,459 shares of the company’s stock after selling 170 shares during the quarter. Global Assets Advisory LLC’s holdings in Procter & Gamble were worth $235,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in PG. Stableford Capital II LLC grew its holdings in Procter & Gamble by 1.1% during the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company’s stock valued at $993,000 after purchasing an additional 61 shares during the period. Bernard Wealth Management Corp. lifted its position in shares of Procter & Gamble by 20.2% during the 1st quarter. Bernard Wealth Management Corp. now owns 375 shares of the company’s stock valued at $64,000 after buying an additional 63 shares during the last quarter. B & T Capital Management DBA Alpha Capital Management lifted its position in shares of Procter & Gamble by 2.3% during the 1st quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company’s stock valued at $476,000 after buying an additional 63 shares during the last quarter. Private Management Group Inc. increased its stake in shares of Procter & Gamble by 4.8% in the first quarter. Private Management Group Inc. now owns 1,384 shares of the company’s stock worth $236,000 after purchasing an additional 64 shares in the last quarter. Finally, Lantz Financial LLC grew its stake in Procter & Gamble by 1.2% in the 2nd quarter. Lantz Financial LLC now owns 5,237 shares of the company’s stock valued at $834,000 after buying an additional 64 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Berenberg Bank raised their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research report on Wednesday, September 17th. Barclays decreased their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. BNP Paribas reaffirmed an “outperform” rating and set a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Procter & Gamble in a report on Saturday, September 27th. Finally, Wells Fargo & Company cut their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Eleven investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $173.11.
Insider Buying and Selling at Procter & Gamble
In other news, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the sale, the chief operating officer owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer directly owned 34,978 shares of the company’s stock, valued at $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by company insiders.
Procter & Gamble Stock Performance
PG stock opened at $150.47 on Tuesday. The stock’s 50 day simple moving average is $155.38 and its 200 day simple moving average is $159.84. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The stock has a market capitalization of $352.17 billion, a PE ratio of 23.11, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The company’s revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- What is a Microcap Stock? Everything You Need to Know
- Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Exceptional Stocks to Build Long-Term Wealth
- Buy P&G Now, Before It Sets A New All-Time High
- Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.